2013		2014		2015		Rate(Cases per 100,000 per month)		Monthly Rate Comparison
Disease	Jan No.	YTD No.	Jan No.	YTD No.	Jan No.	YTD No.	Jan (2010-2014 aggregated)	Jan (2015)	Significant change bet. current & past 5-year?~~
VACCINE PREVENTABLE
DIPHTHERIA	0	0	0	0	0	0	0.00	0.00
HAEMOPHILUS INFLUENZA (INVASIVE)	.	.	.	.	.	.	0.06	0.05
HEPATITIS A	0	0	.	.	0	0	0.02	0.00
HEPATITIS B (ACUTE)	.	.	.	.	0	0	0.11	0.00	X
INFLUENZA**	271	271	256	256	268	268	7.35	13.14	X
MEASLES	0	0	0	0	.	.	0.01	0.05
MUMPS	0	0	0	0	0	0	0.00	0.00
PERTUSSIS	15	15	10	10	.	.	0.29	0.15
POLIOMYELITIS	0	0	0	0	0	0	0.00	0.00
RUBELLA	0	0	0	0	0	0	0.00	0.00
TETANUS	0	0	0	0	0	0	0.00	0.00
SEXUALLY TRANSMITTED
AIDS	16	16	21	21	11	11	0.97	0.54
CHLAMYDIA	714	714	787	787	660	660	34.76	32.35
GONORRHEA	187	187	188	188	210	210	7.97	10.29	X
HIV	21	21	25	25	15	15	1.13	0.74
SYPHILIS (EARLY LATENT)	24	24	23	23	5	5	0.94	0.25	X
SYPHILIS (PRIMARY & SECONDARY)	8	8	21	21	9	9	0.52	0.44
ENTERICS
AMEBIASIS	.	.	0	0	0	0	0.06	0.00	X
BOTULISM-INTESTINAL (INFANT)	0	0	0	0	0	0	0.00	0.00
CAMPYLOBACTERIOSIS	5	5	9	9	.	.	0.43	0.10	X
CHOLERA	0	0	0	0	0	0	0.00	0.00
CRYPTOSPORIDIOSIS	.	.	.	.	.	.	0.02	0.05
GIARDIA	.	.	.	.	.	.	0.20	0.10
ROTAVIRUS	11	11	0	0	.	.	0.12	0.10
SALMONELLOSIS	9	9	5	5	5	5	0.41	0.25
SHIGA-TOXIN PRODUCING E. COLI#	.	.	0	0	.	.	0.07	0.05
SHIGELLOSIS	.	.	.	.	.	.	0.13	0.05
TYPHOID FEVER	0	0	0	0	0	0	0.01	0.00
VIBRIO (NON-CHOLERA)	0	0	.	.	0	0	0.01	0.00
YERSINIOSIS	.	.	.	.	0	0	0.02	0.00
OTHER
ANTHRAX	0	0	0	0	0	0	0.00	0.00
BOTULISM INTOXICATION	0	0	0	0	0	0	0.00	0.00
BRUCELLOSIS	0	0	0	0	0	0	0.00	0.00
COCCIDIOIDOMYCOSIS	.	.	.	.	.	.	0.34	0.20
DENGUE FEVER	0	0	.	.	0	0	0.02	0.00
ENCEPHALITIS	.	.	0	0	0	0	0.01	0.00
HANTAVIRUS	0	0	0	0	0	0	0.00	0.00
HEMOLYTIC UREMIC SYNDROME (HUS)	0	0	0	0	0	0	0.00	0.00
HEPATITIS C (ACUTE)	0	0	0	0	0	0	0.01	0.00
HEPATITIS D	0	0	0	0	0	0	0.00	0.00
INVASIVE GROUP A STREP.##	0	0	0	0	0	0	0.03	0.00
LEGIONELLOSIS	.	.	0	0	.	.	0.04	0.10
LEPROSY (HANSEN’S DISEASE)	0	0	0	0	0	0	0.01	0.00
LEPTOSPIROSIS	0	0	0	0	0	0	0.00	0.00
LISTERIOSIS	0	0	0	0	0	0	0.01	0.00
LYME DISEASE	0	0	0	0	0	0	0.01	0.00
MALARIA	.	.	0	0	0	0	0.03	0.00
MENINGITIS, ASEPTIC/VIRAL	.	.	0	0	.	.	0.09	0.10
MENINGITIS, BACTERIAL	.	.	0	0	.	.	0.01	0.15
MENINGOCOCCAL DISEASE	0	0	0	0	0	0	0.02	0.00
PLAGUE	0	0	0	0	0	0	0.00	0.00
PSITTACOSIS	0	0	0	0	0	0	0.00	0.00
Q FEVER	0	0	0	0	0	0	0.00	0.00
RABIES (HUMAN)	0	0	0	0	0	0	0.00	0.00
RELAPSING FEVER	0	0	0	0	0	0	0.00	0.00
ROCKY MOUNTAIN SPOTTED FEVER	0	0	0	0	0	0	0.00	0.00
RSV (RESPIRATORY SYNCYTIAL VIRUS)	487	487	173	173	335	335	14.45	16.42
STREPTOCOCCUS PNEUMONIAE, IPD###	9	9	12	12	20	20	0.41	0.98	X
TOXIC SHOCK SYN	0	0	0	0	0	0	0.01	0.00
TOXIC SHOCK SYN (STREPTOCOCCAL)	.	.	0	0	0	0	0.02	0.00
TUBERCULOSIS	5	5	.	.	8	8	0.24	0.39
TULAREMIA	0	0	0	0	0	0	0.00	0.00
UNUSUAL ILLNESS	0	0	0	0	0	0	0.01	0.00
WEST NILE VIRUS (ENCEPHALITIS)	0	0	0	0	0	0	0.00	0.00
WEST NILE VIRUS (FEVER)	0	0	0	0	0	0	0.00	0.00

*Rate denominators were spline-interpolated population estimates/projections based on demographic data subject to ongoing revision by the state demographer (last revision as of Oct-2013). Use of onset date to count OOE-reported cases (since Jan-2013) causes changes in cases reported here from previously released reports. Numbers are provisional including confirmed, probable and suspect (since Feb-08) cases. HIV/AIDS case counts provided by Office of HIV/AIDS/STD; TB case counts provided by TB clinic. Data suppression denoted by ‘.’ applies if number of cases <5. Monthly disease total reported by OOE=653(reported total=1571). Due to unavailability of current birth data, congenital syphilis rates were not calculated(reported monthly cases [suppression applied] for 2013-2015 were respectively 0,0,0; YTD totals 0,0,0).

**Reporting of novel type A influenza (reclassified as INFLU OUTBRK per CDC recommendations as of Jan-11) started in May-09.

#E. COLI O157:H7 instead of STEC was reported prior to 2006.

##Reported since Mar-07.

###S. pneumo invasive diseases (reported since Sep-05) previouly reported under separate categories grouped together as of Jan-11 per CDC recommendations.

~~Confidence intervals (not shown) for the monthly disease incidence rates provided a basis for an informal statistical test to determine if the current monthly rates changed significantly from those of the previous 5 years aggregated. Text in green where rates decreased and in red where rates increased. Statistically significant changes indicated by ‘X’ (rate comparisons made if 5+ cases reported in the current month of this year or previous 5 years aggregated).